Competitive Advantages
- User-friendly and low-cost mobile application
- Enables early diagnosis of disease
- Sensitive, specific, and accurate results
Summary
Chronic Obstructive Pulmonary Disease (COPD) and Congestive Heart Failure (CHF) are progressive disorders and often the terminal stage of pulmonary and cardiac disease leading to death. The current US estimates of COPD and CHF cases are 16 million and 6.5 million, respectively. Physicians gauge onset and severity of COPD and CHF by listening to patient’s cough. TussisWatch, a smart-phone based system can record and detect cough patterns indicative of COPD or CHF, using a two-level classification scheme. Through a preliminary test in a cohort of 9 COPD, 9 CHF, and 18 control subjects varying in gender, race, and age, the system demonstrated a high level of sensitivity, specificity, and accuracy. The proposed system is user-friendly and low cost to enable self-diagnosis of COPD and CHF by patients. It has the potential to aid early access to healthcare and may also be used to educate patients on self-care at home.
Desired Partnerships
- License
- Sponsored Research
- Co-Development